MetaCap

IDEXX Laboratories Inc. Company Profile

NASDAQ: IDXXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

518.00+4.86 (+0.95%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

IDEXX Laboratories at a glance

IDEXX Laboratories Inc. (NASDAQ: IDXX) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector headquartered in Westbrook, ME. IDEXX Laboratories is led by Mr. Michael G. Erickson Ph.D. and employs about 11,000 people. The company's shares have traded publicly since 1991.

At a market capitalization of $40.43 billion, it is considered a large-cap company. IDXX is a member of the SP500, NDX. Its SEC Central Index Key (CIK) is 0000874716, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does IDEXX Laboratories do?

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Business description based on the company's public filings.

Company information

Legal name
IDEXX Laboratories Inc.
Ticker
NASDAQ: IDXX
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
CEO
Mr. Michael G. Erickson Ph.D.
Employees
11,000
Headquarters
One IDEXX Drive, Westbrook, ME, United States
Phone
207 556 0300
Website
idexx.com
IPO year
1991
Market cap
$40.43B
SEC CIK
0000874716
Latest annual report
10-K · Feb 20, 2026

Index membership

Companies similar to IDEXX Laboratories

IDXX peer companies
CompanyPrice% ChgMarket capCompare
LNTHLantheus Holdings Inc.100.15+0.03%$6.54Bvs IDXX
ORKAOruka Therapeutics Inc.82.11+6.25%$5.44Bvs IDXX
NEOGNeogen Corporation11.85+1.20%$2.59Bvs IDXX
CLDXCelldex Therapeutics Inc.29.89+2.01%$2.35Bvs IDXX
NTLAIntellia Therapeutics Inc.13.07+3.73%$1.83Bvs IDXX
QDELQuidelOrtho Corporation13.42+8.14%$920.28Mvs IDXX
ACHVAchieve Life Sciences Inc.7.41+3.06%$763.99Mvs IDXX
TKNOAlpha Teknova Inc.8.84+4.74%$474.60Mvs IDXX

Related